Cocoon CEO Ailis Tweed-Kent to Present at Bio-Europe Spring 2016

Ailis Tweed-Kent, CEO and Founder of Cocoon Biotech, Inc., has been invited to speak at Bio-Europe Spring 2016, held April 4-6 in Stockholm, Sweden. On Monday, April 4 at 4:00 p.m. she will be a panelist on “The New Normal:  Effective Alternative Financing,” and on Tuesday, April 5 at 11:30 p.m. she will tell the Cocoon story at the company presentation session, which will provide a forum for 129 innovative startups, established biotech companies, and large and midsize pharma companies to present information on products, partnering opportunities and corporate strategy.

For more information about Bio-Europe Spring 2016, visit this page.

Cocoon to Present at 2015 OARSI World Congress

Cocoon Biotech has been invited to participate in the 2015 Osteoarthritis Research Society International (OARSI) World Congress to be held in Seattle, Washington from April 30 to May 3, 2015. The OARSI Congress is an annual forum for anyone involved in osteoarthritis research or treatment, and it brings together a wide variety of scientists, health professionals and policy makers for workshops, plenary sessions and mentorship. The interdisciplinary nature of the congress provides many opportunities for networking and allows both young researchers and experts to share their ideas and progress. This year, some of the topics to be discussed are joint development, genetic risks for OA, and pain mechanisms behind OA. Corporate sponsors of the congress include Abbvie, Bioiberica, and EMD Serono.

Team members from Cocoon will be presenting a poster on Intra-Articular Augmentation of Lubrication with Silk Microspheres on Friday May 1st and Saturday May 2nd. They will also have a chance to speak with clinical experts and research leaders at mentorship sessions and breakfast workshops.

For more information about the OARSI World Congress, visit their website.